Fortrea Holdings Inc.
FTRE · XNASCIK 1965040fmd_15JHDVH1AHDW42JGAXK92ZGN2NServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2021 to Sep 30, 2026, 20 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | 3,058 | 2,837 | 2,843 | 2,696 | 2,723 |
| Net interest income | – | (0) | (70) | – | – |
| Selling, general and administrative | 303 | 416 | 448 | 561 | 456 |
| Operating income | 114 | 187 | 32 | (162) | (873) |
| Interest expense | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | 2 | 2 | 7 | 21 | 8 |
| Income before taxes | 136 | 187 | (31) | (275) | (983) |
| Income tax expense | 38 | 41 | 1 | (4) | 3 |
| Net income from continuing operations | 98 | 146 | (32) | (272) | (986) |
| Net income | 98 | 186 | (25) | (329) | (986) |
| Net income to common shareholders | 98 | 193 | (3) | – | – |